US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Pharmaceuticals Company Reports Industry Research & Market Reports

1  2  3    5    7  8  9  10  
Calox Dominicana SA in Consumer Health (Dominican Republic)
4/15/2015 | published by: Euromonitor International
... quality standards. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection ...  |  read more...
USD 150
Darou Pakhsh Pharmaceutical Mfg Co in Consumer Health (Iran)
4/14/2015 | published by: Euromonitor International
... plans to become the largest producer of OTC and Rx drugs in Iran by expanding its product portfolio. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by ...  |  read more...
USD 150
GlaxoSmithKline East Africa Ltd in Consumer Health (Kenya)
4/14/2015 | published by: Euromonitor International
... Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot ...  |  read more...
USD 150
Regal Pharmaceuticals Ltd in Consumer Health (Kenya)
4/14/2015 | published by: Euromonitor International
... a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles. Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric OTC Healthcare, Sports Nutrition, Vitamins and Dietary ...  |  read more...
USD 150
Angelini Farmacêutica Lda in Consumer Health (Portugal)
4/22/2015 | published by: Euromonitor International
... in profitability in prescription medicines. To do so, the company has tried to reinforce its market position within non-reimbursed medicines such as OTC products, personal care products and dietary supplements, which have lower margins but ...  |  read more...
USD 150
Aversi-Pharma Co Ltd in Retailing (Georgia)
4/23/2015 | published by: Euromonitor International
... OTC manufacturing. One of the company’s most successful actions was the establishment of clinic branches. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover ...  |  read more...
USD 150
Centrala Farmaceutyczna Cefarm in Consumer Health (Poland)
4/24/2015 | published by: Euromonitor International
... and the adoption of global standards of Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). The company tends to establish cooperation with manufacturers in the field of marketing and distribution of new brands and ...  |  read more...
USD 150
EPSA SA in Health and Wellness (Greece)
4/21/2015 | published by: Euromonitor International
... and wellness beverages and in new product launches. EPSA SA will continue to invest heavily in R&D in order to introduce innovative products, staying ahead in terms of developments and keep up with global trends. ...  |  read more...
USD 150
Erbak-Uludag Mesrubatlari AS in Health and Wellness (Turkey)
4/21/2015 | published by: Euromonitor International
... the industrial manufacturing of traditional lemonade product after it launched this product under its Uludag brand in 2007. Over the forecast period, the company will seek to preserve its share as the dominant juice drinks ...  |  read more...
USD 150
Aileron Therapeutics, Inc. - Product Pipeline Review - 2015
4/15/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Aileron Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Minoryx Therapeutics s.l. - Product Pipeline Review - 2015
4/15/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Minoryx Therapeutics s.l.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Ambryx Biotechnology, Inc. - Product Pipeline Review - 2015
4/15/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Ambryx Biotechnology, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Aureogen Biosciences, Inc. - Product Pipeline Review - 2015
4/15/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Aureogen Biosciences, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
CLL Pharma - Product Pipeline Review - 2015
4/15/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of CLL Pharma’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015
5/1/2015 | published by: Current Partnering
... financing deals. Comprehensive directory of royalty financing deals since 2007 Royalty financing contract documents Royalty financing agreement terms Royalty financing agreement structure Top royalty financing deals by value Most active Royalty financing dealmakers The Global ...  |  read more...
USD 1,995
Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2010-2015
5/1/2015 | published by: Current Partnering
... evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter option and evaluation deals. The majority of deals are multicomponent ...  |  read more...
USD 2,995
Retinopathy Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... listed by company A-Z, industry sector, stage of development, technology type The Retinopathy Partnering 2010-2015 provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. The ...  |  read more...
USD 795
Viral Partnering Terms and Agreements
5/1/2015 | published by: Current Partnering
... terms for headline, upfront and royalty by stage of development Viral partnering agreement structure Viral partnering contract documents Top viral deals by value Most active viral dealmakers The Viral Partnering Terms and Agreements report provides ...  |  read more...
USD 1,795
MRSA Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... listed by company A-Z, industry sector, stage of development, technology type The MRSA Partnering 2010-2015 provides understanding and access to the MRSA partnering deals and agreements entered into by the worlds leading healthcare companies. The ...  |  read more...
USD 795
Hepatitis Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... listed by company A-Z, industry sector, stage of development, technology type The Hepatitis Partnering 2010-2015 provides understanding and access to the hepatitis partnering deals and agreements entered into by the worlds leading healthcare companies. The ...  |  read more...
USD 995
Herpes simplex Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Herpes Simplex Partnering 2010-2015 provides understanding and access to the herpes simplex partnering deals and agreements entered into by ...  |  read more...
USD 795
HIV Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... listed by company A-Z, industry sector, stage of development, technology type The HIV Partnering 2010-2015 provides understanding and access to the HIV partnering deals and agreements entered into by the worlds leading healthcare companies. The ...  |  read more...
USD 1,795
Tropical Disease Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Tropical Diseases Partnering 2010-2015 provides understanding and access to the tropical diseases partnering deals and agreements entered into by ...  |  read more...
USD 795
Dengue Fever Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dengue fever Partnering 2010-2015 provides understanding and access to the dengue fever partnering deals and agreements entered into by ...  |  read more...
USD 795
Human Papilloma Virus Partnering 2010-2015
5/1/2015 | published by: Current Partnering
... Top human papilloma virus deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Human Papilloma virus Partnering 2010-2015 provides understanding and access to the human papilloma virus partnering ...  |  read more...
USD 795
1  2  3    5    7  8  9  10